Onset Therapeutics Announces Agreement with Managed Healthcare Associates (MHA); Optase(TM) is the first product subject to the Agreement.WOONSOCKET, R.I. -- Onset Therapeutics, a specialty pharmaceutical company focused on the development and commercialization of innovative, patent protected topical products for skin and wound related disorders, announced today that they have signed an agreement with Managed Healthcare Associates (MHA MHA microangiopathic hemolytic anemia. ), the largest Group Purchasing Organization A group purchasing organization is an entity that leverages the purchasing power of a group of businesses to obtain discounts from vendors based on the collective buying power of the GPO members. Many GPOs are funded by administrative fees that are actually paid by the vendors. (GPO) in the Alternate Site and Long-Term Care long-term care (LTC), n the provision of medical, social, and personal care services on a recurring or continuing basis to persons with chronic physical or mental disorders. (LTC LTC abbr. lieutenant colonel ) Industry. MHA's members will be able to purchase Onset products according to the terms of the agreement. Optase(TM) (Trypsin trypsin, enzyme that acts to degrade protein; it is often referred to as a proteolytic enzyme, or proteinase. Trypsin is one of the three principal digestive proteinases, the other two being pepsin and chymotrypsin. , Balsam balsam (bôl`səm), fragrant resin obtained from various trees. The true balsams are semisolid and insoluble in water, but they are soluble in alcohol and partly so in hydrocarbons. Peru, Castor Oil castor oil, yellowish oil obtained from the seed of the castor bean. The oil content of the seeds varies from about 20% to 50%. After the hulls are removed the seeds are cold-pressed. ), a prescription product in a patent pending Gel formulation for topical application on a wide variety of wounds, is the first in a series of prescription products expected to be introduced this year by Onset Therapeutics and the first to be offered to MHA members. Optase(TM) is currently available through drug wholesalers nationwide. "We are excited to have entered into this agreement with MHA for Optase(TM)," states Michael Heffernan, President, Onset Therapeutics. "We believe that this agreement will be beneficial to MHA's members and the patients they serve. MHA's endorsement of Optase(TM) is an important step in the launch of the product because we consider MHA to be a significant player in the long term care market, servicing more that 540,000 long term beds in the U.S." "We continually strive to offer our members products that provide clinical and economic advantages within a therapeutic category", states Dan Sanders, VP Contracting and Business Development of MHA. "After completing a product review of Optase(TM), we believe the product may have some clinical and economic advantages in the wound care market, and that this agreement will provide benefits to our members." With significant development capabilities that include formulation development through GMP GMP (guanosine monophosphate): see guanine. manufacturing, Onset expects to market numerous topical products within the wound care and dermatology markets in 2006. In addition, the company has a full pipeline of products that it intends to launch over the next 3 years. About Onset Therapeutics Onset Therapeutics is a privately held specialty pharmaceutical company focusing on the development and commercialization of novel, patent protected topical products for the treatment of wounds and skin disorders. For more information, please visit the company's website at www.onsettx.com About MHA Managed Health Care Associates, Inc. (MHA) has grown to become the leading Alternate Site GPO and Long Term Care Pharmacy Network Manager servicing the Independent LTC Pharmacy industry. MHA's success is driven by unparalleled member support, competitive contracts, and the ability to create sophisticated, customized, web tools and reports designed to increase savings and promote profitability. Members utilize MHA's services to assist in the purchasing of a complete line of pharmaceuticals, medical supplies, capital equipment, and food products. Members also have access to a comprehensive network of national and regional prescription drug prescription drug Prescription medication Pharmacology An FDA-approved drug which must, by federal law or regulation, be dispensed only pursuant to a prescription–eg, finished dose form and active ingredients subject to the provisos of the Federal Food, Drug, plans managing the newly created Medicare Part D drug benefit through the MHA LTC Network. MHA's pharmaceutical manufacturer, medical supply, and prescription drug plan business partners benefit from a range of services including contract administration, marketing, and continuing education. |
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion